I got in at 2.25 thinking it might bounce back to 2.75.Bounced off 2.00 to 2.25 pretty dang quick
2.45... almost there...I got in at 2.25 thinking it might bounce back to 2.75.
Barring bad news, it seems like 2.00 is strong support. Has hit that and bounced a few times since the big pop.Bounced off 2.00 to 2.25 pretty dang quick
I missed by seconds of getting more at 2.05.Barring bad news, it seems like 2.00 is strong support. Has hit that and bounced a few times since the big pop.
Eh, I mean market is irrational now. Last week's rally was on nothing. Market up today on 6 million people filing for unemployment.Markets sharply reversing course - thinking CNN's news that talking and breathing spreads this thing too the likely culprit. FML.
This is how they shake out the weak both long and short.Eh, I mean market is irrational now. Last week's rally was on nothing. Market up today on 6 million people filing for unemployment.
Certainly does. I had an OTC BNTI back then. Over 6 years, I accumulated 130,000 shares. avg 0.24. It traded between 0.10 and 1.00 for those 6 years. In 2000, it was at .30 to .40 for a long time, then jumped to a $1, then $2.50, then hit a high of $6.75. Sold it all at $2.90. Was going to exit at 7.65 and just missed it.Got some Deva-Vu from 1998-2000 going.
Dr. Patterson explains it well. Dr. Pourhassan less well.Another interview. Seemed a little squirrelly on actual outcomes of the 8 that have 3 days worth of time elapsed.
Fidelity would let me buy immediately.Argh tried to load up on more at $2.10 but didn't have any liquid cash in my brokerages that allow me to trade OTC and it wouldn't let me buy with instant deposit funds on TD Ameritrade.
Any brokers that will let you use instant deposit buying power on options and penny stocks or is that pretty much a no-go everywhere?
Is MRO the one to hop on when the new lows are tested? What makes them better than others? (Cheapest with most room to run?)It's coming back down.
Ehh I am not sure - it's probably just my communication style is more...blunt. Like, there are only 8 patients - it shouldn't be hard to say exactly what is happening (unless perhaps that something isn't necessarily great):Dr. Patterson explains it well. Dr. Pourhassan less well.
What did you find squirrelly? IMO, the PR didn't clearly explain that they were only releasing data on 8/10 because they only have the day-3 data on the first 8 patients. To me, it implied that the other two patients didn't respond. I thought the video actually did a good job of clarifying that issue. Dr. Pourhassan said that one patient is ready to be discharged and 2 were out of the ICU. He also mentioned that they did a study in China on similarly ill patients and 31/32 died.
RobinhoodArgh tried to load up on more at $2.10 but didn't have any liquid cash in my brokerages that allow me to trade OTC and it wouldn't let me buy with instant deposit funds on TD Ameritrade.
Any brokers that will let you use instant deposit buying power on options and penny stocks or is that pretty much a no-go everywhere?
There may be some protocol they're following but I also think they wanted to be consistent with the first PR which announced the day-3 results of the first 4 patients. I agree if they could clearly trace the path of each patient--there are only 10--it would be easier to follow in some ways but more confusing in others: there was about a ~10-day lag from patient 1 to patient 10.Ehh I am not sure - it's probably just my communication style is more...blunt. Like, there are only 8 patients - it shouldn't be hard to say exactly what is happening (unless perhaps that something isn't necessarily great):
I'm long (both in the stock & my desire for it to actually help people) - but just thought using vague language (many, some, most) when talking about .... 8 people is maybe a red flag. Shrug. I also watched/listened to the video while doing other work so grains of salt encouraged.
- We have injected ten patients - we are discussing 8 only because the last 2 haven't had a full 3 days since injection (perhaps a clarification of why 3 days matters here)
- Important to note these 8 were very sick - comparative to patients in China where 31/32 died
- X/8 were on ventilators when drug administered
- Y/8 are no longer on ventilators (I think this is 2)
- Z/8 have been removed from the ICU
- A/8 are still on ventilators but have shown signs of improvement (or not)
I picked the ones that were making money before this. MRO and CPE.Is MRO the one to hop on when the new lows are tested? What makes them better than others? (Cheapest with most room to run?)
Don't forget to thank @BassNBrew for this opportunity.C'mon Marriott, a little more and I am in.
Get ready to buy...
Just bought some CYDY, DAL, and AAL
and MAR
Spillover from the ATHX negative article on SA today.This is weird. No buyers.
Link and quote plsSpillover from the ATHX negative article on SA today.
SA article. No paywall, so good to read. Basically "they're claiming success, but are torturing the data and really failed." I assume a short operator wrote this (and they may be right with that one, who knows).chet said:Link and quote pls
All down after I bought.caustic said:Don't forget to thank @BassNBrew for this opportunity.matuski said:C'mon Marriott, a little more and I am in.![]()
BassNBrew said:Get ready to buy...
Just bought some CYDY, DAL, and AAL
and MAR
no way, it's trading like 60k shares per minuteI think FBGs are the only CYDY buyers....single handedly propping up demand?
I hate reusing a joke, but, your avatar matches up with your posts SOOO much. "Avatar checks out".All down after I bought.
We got some ballers here.no way, it's trading like 60k shares per minute
It's OK.I hate reusing a joke, but, your avatar matches up with your posts SOOO much. "Avatar checks out".
Hang in there, GB!
“When we study the short selling volume data for OTC stocks published by Financial Industry Regulatory Authority (FINRA), we find that on average, short selling constitutes 48% of the tradingvolume. This makes intuitive sense as the OTC markets should be more attractive to short sellers as they are less transparent, less liquid, and are not as regulated as exchange traded stocks. An average negative return in OTC markets also makes an attractive playground to short sellers. Thus, acquiring information about these stocks can result in potentially higher returns for traders. Also, as these markets are less regulated, it makes it easier for short sellers to manipulate stock prices in the downward direction.”
Standing by this and recommend selling here every time until it proves me otherwise. In hindsight, this was an excellent call. If it gets near there again, barring some sort of real path forward, I'm sticking with this.22,500 is the ceiling.